Conjugated linoleic acid (CLA) has been shown to inhibit carcinogenesis and atherosclerosis, enhance immunologic function while protecting against the catabolic effects of immune stimulation, affect body composition change (reducing body fat gain while enhancing lean body mass gain), and stimulate the growth of young rats. We discuss possible biochemical mechanisms that underlie these physiological effects. We emphasize the Importance of considering the effects, both individually and combined, of the two CLA isomers (cis-9, trans-11 CLA and trans-10, cis-12 CLA) that have been shown to exhibit biological activity and which appear to exert their effects via different biochemical mechanisms.
Get full access to this article
View all access options for this article.
References
1.
HaYL, GrimmNK, ParizaMW. Anticarcinogens from fried ground beef: Heat-altered derivatives of linoleic acid. Carcinogenesis8: 1881–1887, 1987.
2.
CookME, MillerCC, ParkY, ParizaMW. Immune modulation by altered nutrient metabolism: Nutritional control of immune-induced growth depression. Poultry Sci72: 1301–1305, 1993.
3.
MillerCC, ParkY, ParizaMW, CookME. Feeding conjugated linoleic acid to animals partially overcomes catabolic responses due to endotoxin injection. Biochem Biophys Res Commun198: 1107–1112, 1994.
4.
ChinSF, StorksonJM, AlbrightKJ, CookME, ParizaMW. Conjugated linoleic acid is a growth factor for rats as shown by enhanced weight gain and improved feed efficiency. J Nutr124: 2344–2349, 1994.
5.
ParkY, AlbrightKJ, StorksonJM, CookME, ParizaMW. Effect of conjugated linoleic acid on body composition in mice. Lipids32: 853–858, 1997.
6.
LeeKN, KritchevskyD, ParizaMW. Conjugated linoleic acid and atherosclerosis in rabbits. Atherosclerosis108: 19–25, 1994.
7.
DoyleE.Scientific forum explores CLA knowledge. INFORM9: 69–72, 1998.
8.
ChristieWW. Isomers in commercial samples of conjugated linoleic acid. J AOCS Int74: 1231, 1997.
9.
SenatN, YuraweczMP, RoachJAG, MossobaMM, KramerJKG, KuY.Silver-ion high-performance liquid chromatographic separation and identification of conjugated linoleic acid isomers. Lipids33: 217–221, 1998.
KramerJKG, FellnerV, DuganMER, SauerFD, MossobaMM, YuraweczMP. Evaluating acid and base catalysts in the methylation of milk and rumen fatty acids with special emphasis on conjugated dienes and total trans fatty acids. Lipids32: 1219–1228, 1997.
14.
KeplerCR, HironsKP, McNeillJJ, ToveSB. Intermediates and products of the biohydrogenation of linoleic acid by Butyrivibrio fibrisolvens. J Biol Chem241:1350–1354, 1966.
15.
HolmanRT, MahfouzMM. Cis- and trans-octadecadienoic acids as precursors of polyunsaturated fatty acids. Prog Lipid Res20: 151–156, 1980.
16.
PollardMR, GunstoneFD, JamesAT, MorrisU.Desaturation of positional and geometric isomers of monoenoic fatty acids by microsomal preparations from rat liver. Lipids15: 306–314, 1980.
17.
GriinariJM, BaumanDE. Biosynthesis of conjugated linoleic acid and its incorporation into meat and milk in ruminants. In: YuraweczMP, MossobaMM, KramerJKG, ParizaMW, NelsonG, Eds. Advances in Conjugated Linoleic Acid Research, Vol. 1. Champaign, IL: AOCS Press, pp 180–200, 1999.
VerhulstA, JanssenG, ParmentierG, EyssenH.Isomerization of polyunsaturated long chain fatty acids by Propionibacteria. Syst Appl Microbiol9: 12–15, 1987.
20.
ParkY, ParizaMW. Evidence that commercial calf and horse sera can contain substantial amounts of trans-10, cis-12 conjugated linoleic acid. Lipids33: 817–819, 1998.
21.
UchidaK.Occurrence of conjugated dienoic fatty acids in the cellular lipids of Pediococcus homari. Agric Biol Chem39:561–563, 1975.
22.
ParkY, AlbrightKJ, StorksonJM, LiuW, ParizaMW. Evidence that the trans-10, cis-12 isomer of conjugated linoleic acid induces body composition changes in mice. Lipids34: 235–241, 1999.
23.
de DeckereEAM, van AmelsvoortJMM, RudrumM, LinY.Effects of different conjugated linoleic acid isomers on lipid variables in the hamster. FASEB J13: LB48, 1999.
24.
LinYG, DraijerR, KreeftA, de DeckereEAM, RudrumM, TijburgL.Differential effects of conjugated linoleic acid isomers on lipid metabolism in vitro. FASEB J13: L#207, 1999.
ChewBT, WongTS, ShultzTD, MagnusonNS. Effects of conjugated dieonic derivatives of linoleic acid and β-carotene in modulating lymphocyte and macrophage function. Anticancer Res17: 1099–1106, 1997.
34.
SuganoMA, TsujitaM, YamasakiK, IkedaI, KritchevskyD.Lymphatic recovery, tissue distribution, and metabolic effects of conjugated linoleic acid in rats. J Nutr Biochem8: 38–43, 1997.
35.
WongMW, ChewBP, WongTS, HosickHL, BoylstonTD, ShultzTD. Effects of dietary conjugated linoleic acid on lymphocyte function and growth of mammary tumors in mice. Anticancer Res17: 987–993, 1997.
36.
WhighamLD, HigbeeAJ, ParizaMW, CookME. Influence of dietary conjugated linoleic acid on release of PGE2 and LTB4 from guinea pig lung, trachea, and bladder. FASEB J13: 4566, 1999.
37.
BeluryM, Vanden HeuvelJP. Modulation of diabetes by conjugated linoleic acid. In: YuraweczMP, MossobaMM, KramerJKG, ParizaMW, NelsonG, Eds. Advances in Conjugated Linoleic Acid Research, Vol. I. Champaign, IL: AOCS Press. pp 404–411, 1999.
38.
Moya-CamarenaSY, Vanden HeuvelJP, BeluryMA. Conjugated linoleic acid activates peroxisome proliferator-activated receptor a and b subtypes but does not induce hepatic peroxisome proliferation in Sprague-Dawley rats. Biochim Biophys Acta1436: 331–342, 1999.
39.
IpC, SinghM, ThompsonHJ, ScimecaJA. Conjugated linoleic acid suppresses mammary carcinogenesis and proliferative activity of the mammary gland in the rat. Cancer Res54: 1212–1215, 1994.
40.
BanniS, AngioniE, CasuV, MelisMP, ScrugliS, CartaG, CorongiuFP, IpC.An increase in vitamin A status by the feeding of conjugated linoleic acid. Nutr Cancer33: 53–57, 1999.
41.
LiewC, SchutHAJ, ChinSF, ParizaMW, DashwoodRH. Protection of conjugated linoleic acids against 2–amino-3-methylimidazo[4,5-f]quinoline-induced colon carcinogenesis in the F344 rat: A study of inhibitory mechanisms. Carcinogenesis16: 3037–3043, 1995.
42.
ParizaMW, ParkY, CookME. Conjugated linoleic acid and the control of cancer and obesity. Toxicological Sciences, 52(Suppl):107–110, 1999.
43.
MamettLJ. Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res52: 5575–5589, 1992.
44.
BrodieAE, ManningVA, FergusonKR, JewellDE, HuCY. Conjugated linoleic acid inhibits differentiation of pre- and post-confluent 3T3–L1 preadipocytes but inhibits cell proliferation only in preconfluent cells. J Nutr129: 602–606, 1999.
45.
ParkY, AlbrightKJ, StorksonJM, LiuW, CookME, ParizaMW. Changes in body composition during feeding and withdrawal of dietary conjugated linoleic acid. Lipids34: 243–248, 1999.
46.
LiY, WatkinsBA. Conjugated linoleic acids alter bone fatty acid composition and reduce ex vivo prostaglandin E2 biosynthesis in rats fed n-6 or n-3 fatty acids. Lipids33: 417–425, 1998.
47.
SebedioJL, JuanedaP, DobsonG, RamilisonI, MartinJC, ChardignyJM, ChristieWW. Metabolites of conjugated isomers of linoleic acid (CLA) in the rat. Biochim Biophys Acta1345: 5–10, 1997.
48.
ParizaMW, ParkY, AlbrightKJ, LiuW, StorksonJM, CookME. Synthesis and biological activity of conjugated eicosadienoic acid. Abstracts of the 89th American Oil Chemists Society Annual Meeting, 21, 1998.
GarofaloA, ChiriviRGS, FoglieniC, PigottR, MortariniR, Martin-PaduraI, AnichiniA, GearingAJ, Sanchez-MadridF, DejanaE, GiavazziR.Involvement of the very late antigen 4 integrin on melanoma in interleukin 1-augmented experimental metastasis. Cancer Res55: 414–519, 1995.
RossR.The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature362: 801–809, 1993.
56.
OkaharaH, YagitaH, MiyakeK, OkumuraK.Involvement of very late activation antigen 4 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) in tumor necrosis factor a enhancement of experimental metastasis. Cancer Res54: 3233–3236, 1994.
57.
SuganumaM, OkabeS, SueokaE, IidaN, KomoriA, KimSJ, FugikiH.A new process of cancer prevention mediated through inhibition of tumor necrosis factor o expression. Cancer Res56: 3711–3715, 1996.
58.
SteinhartC.Conjugated linoleic acid: The good news about animal fat. J Chem Educ73: A302–A303, 1996.
